--- title: "GKHT Medical Technology Co., Ltd. (301370.SZ)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/301370.SZ.md" symbol: "301370.SZ" name: "GKHT Medical Technology Co., Ltd." industry: "Health Care Distributors" --- # GKHT Medical Technology Co., Ltd. (301370.SZ) | Item | Detail | |------|--------| | Industry | Health Care Distributors | | Location | CN Market | | Website | [www.gkht.com](https://www.gkht.com) | ## Company Profile GKHT Medical Technology Co., Ltd. distributes and sells medical devices in China. The company offers vascular interventional therapy materials, orthopedic materials, neurosurgical materials, non-vascular interventional therapy materials, and dental materials. It also provides logistics and distribut... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-21T04:30:10.000Z **Overall: C (0.46)** **Industry**: Health Care Distributors | Metric | Value | |--------|-------| | Industry Ranking | 16 / 25 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 0.26% | | | Net Profit YoY | -39.59% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 2.14 | | | Dividend Ratio | 0.73% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 5.37B | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 7.22B | | **Multi Score**: C #### Profit Score: C | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 3.97% | C | | Profit Margin | 1.36% | C | | Gross Margin | 10.40% | E | #### Growth Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 0.26% | C | | Net Profit YoY | -39.59% | D | | Total Assets YoY | -9.04% | E | | Net Assets YoY | 1.72% | C | #### Cash Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | 7348.63% | A | | OCF YoY | 0.26% | C | #### Operating Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 1.09 | A | #### Debt Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 59.50% | D | ```chart-data:radar { "title": "Longbridge Financial Score - GKHT Medical Technology Co., Ltd.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "C", "indicators": [ { "name": "ROE", "value": "3.97%", "rating": "C" }, { "name": "Profit Margin", "value": "1.36%", "rating": "C" }, { "name": "Gross Margin", "value": "10.40%", "rating": "E" } ] }, { "name": "Growth", "grade": "D", "indicators": [ { "name": "Revenue YoY", "value": "0.26%", "rating": "C" }, { "name": "Net Profit YoY", "value": "-39.59%", "rating": "D" }, { "name": "Total Assets YoY", "value": "-9.04%", "rating": "E" }, { "name": "Net Assets YoY", "value": "1.72%", "rating": "C" } ] }, { "name": "Cash", "grade": "B", "indicators": [ { "name": "Cash Flow Margin", "value": "7348.63%", "rating": "A" }, { "name": "OCF YoY", "value": "0.26%", "rating": "C" } ] }, { "name": "Operating", "grade": "A", "indicators": [ { "name": "Turnover", "value": "1.09", "rating": "A" } ] }, { "name": "Security", "grade": "D", "indicators": [ { "name": "Gearing Ratio", "value": "59.50%", "rating": "D" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | HUADONG MEDICINE (SZ.000963) | B | C | A | B | B | B | | 02 | Jointown (SH.600998) | C | B | A | D | B | B | | 03 | SINOPHARM(CNCM LTD) (SH.600511) | C | C | A | C | B | B | | 04 | Shanghai Pharma (SH.601607) | C | C | A | D | B | C | | 05 | GYBYS (SH.600332) | C | C | A | C | B | C | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 54.70 | 17/26 | 56.31 | 52.21 | 42.06 | | PB | 2.14 | 18/26 | 2.20 | 2.14 | 1.99 | | PS (TTM) | 0.74 | 18/26 | 0.76 | 0.72 | 0.67 | | Dividend Yield | 0.73% | 19/26 | 1.24% | 0.78% | 0.72% | ## References - [Company Overview](https://longbridge.com/en/quote/301370.SZ/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/301370.SZ/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/301370.SZ/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.